Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor–Intolerant Patients

INTRODUCTION: Belatacept has shown potential for prevention of rejection after kidney transplantation, given its demonstration of reduced nephrotoxicity in combination with absence of significant incidence of rejection. However, concerns have been raised regarding increased risk of viral infection....

Descripción completa

Detalles Bibliográficos
Autores principales: Schaenman, Joanna, Rossetti, Maura, Pickering, Harry, Sunga, Gemalene, Wilhalme, Holly, Elashoff, David, Zhang, Qiuheng, Hickey, Michelle, Reddy, Uttam, Danovitch, Gabriel, Reed, Elaine F., Bunnapradist, Suphamai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832066/
https://www.ncbi.nlm.nih.gov/pubmed/36644348
http://dx.doi.org/10.1016/j.ekir.2022.10.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832066/
https://www.ncbi.nlm.nih.gov/pubmed/36644348
http://dx.doi.org/10.1016/j.ekir.2022.10.015

Ejemplares similares